A new op-ed suggests that concerns about “branding” may deter many doctors from offering medication-assisted treatment (MAT) for opioid use disorder.
Tag: buprenorphine
Deregulating Buprenorphine Could Save Thousands Of Lives, Physicians Say
Fewer than 7% of US physicians currently have the DEA waivers necessary to prescribe buprenorphine.
Florida Versus Evidence: How I Lost My Children Because of Past Drug Use
When my first slew of drug tests returned negative, the opposition began slinging whatever they could think of in my direction, hoping something would stick.
How to Taper Off Suboxone: A Survival Guide
“Fear is common and normal for a number of reasons, but the fear usually gives way to a sense of confidence and optimism when a taper is done correctly…Be patient.” Note: This article is not intended as a replacement for medical advice. This is merely the experience of 21 people interviewed by the author who… Continue reading How to Taper Off Suboxone: A Survival Guide
Lawmakers, Healthcare Facility Clash Over Treating Inmates With Addiction
Is the risk of overdose higher in prison or upon release? A fight is underway in the state of Vermont over the execution of legislation designed to provide treatment for prison inmates with addiction. S.166, which was signed into law in May 2018, provides treatment with buprenorphine to inmates with the approval of a doctor—but legislators… Continue reading Lawmakers, Healthcare Facility Clash Over Treating Inmates With Addiction
Will Naloxone Be Co-Prescribed With Opioid Painkillers In The Future?
While some states already require the co-prescription, the FDA is considering making it a requirement across the US. In an effort to decrease overdose deaths, doctors could soon be required to prescribe an opioid overdose antidote any time they prescribe prescription painkillers, according to Food and Drug Administration (FDA) Commissioner Scott Gottlieb. The idea… Continue reading Will Naloxone Be Co-Prescribed With Opioid Painkillers In The Future?
Lack Of Suboxone Access Leads Users In Need To The Black Market
President Trump is expected to sign a bill to expand medication-assisted treatment but it remains unclear as to how soon that will take place. A new feature by NPR underscores a potentially dangerous conundrum for health care professionals and individuals seeking treatment for opioid use disorder: while buprenorphine (also known as Suboxone, Subutex and Zubsolv) has proven effective in blocking… Continue reading Lack Of Suboxone Access Leads Users In Need To The Black Market
An Open Letter to Addiction Treatment Providers
There’s something wrong with addiction patients feeling the need to ask for medical advice from their communities because they don’t trust their providers. Maybe you’re a psychiatrist. Maybe you’re a dosing nurse at a methadone clinic. Maybe you’re an inpatient counselor. Maybe you work in an emergency department, or you’re an OBGYN; maybe you don’t… Continue reading An Open Letter to Addiction Treatment Providers
Why Hospitals Offer Treatment Referrals In Lieu Of Addiction Services?
Only 5% of ER doctors work in hospitals that offer buprenorphine or methadone. A recent Huffington Post feature highlights a conundrum within the medical community’s response to the opioid crisis: emergency room patients with opioid use disorder who receive a dose of buprenorphine are twice as likely to continue treatment within the next 30 days than those who… Continue reading Why Hospitals Offer Treatment Referrals In Lieu Of Addiction Services?
New Dosage Strength Of Opioid Addiction Drug Approved By FDA
The FDA commissioner noted that the approval will expand access for patients and reduce drug development costs. The U.S. Food and Drug Administration (FDA) approved a new dosage strength for a maintenance drug for the treatment of opioid addiction. Cassipa, which is a sublingual (applied under the tongue) film that combines the opioid treatment drug buprenorphine… Continue reading New Dosage Strength Of Opioid Addiction Drug Approved By FDA